Stoke Therapeutics (STOK) PT Raised to $49 at Credit Suisse
Tweet
Share
E-mailGet Alerts STOK Hot Sheet
Price: $32.29 +2.83%
Rating Summary:
14 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
14 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Credit Suisse analyst Martin Auster raised the price target on Stoke Therapeutics (NASDAQ: STOK) to $49.00 (from $42.00) while maintaining a Outperform rating.
You May Also Be Interested In
- JPMorgan Reinstates Stoke Therapeutics (STOK) at Overweight
- Rockwell Automation (ROK) PT Lowered to $490 at DA Davidson
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
